The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207

Trial Profile

The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Dasiglucagon (Primary) ; Glucagon; Insulin lispro
  • Indications Hypoglycaemia
  • Focus Adverse reactions
  • Sponsors Zealand Pharma
  • Most Recent Events

    • 07 Mar 2018 According to Zealand Pharma media release, results from this trial were presented at the Conference on Advanced Technologies & Treatments for Diabetes (2018).
    • 15 Feb 2018 According to Zealand Pharma media release, results (n=12) from this trial will be presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (2018).
    • 22 Jun 2017 Results published in a Zealand Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top